Assignee
HAISCO PHARMACEUTICAL GROUP CO LTD
CN·1 granted patent·4 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0153US2025215008A1Preparation and use of quinazolinone derivative as kinase inhibitorHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 0252US2024400586A1Heteroaryl derivative parp inhibitor and use thereofHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
- 0352US2026027108A1Pharmaceutical composition of heteroaryl derivative and medical use thereofHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 0449US2026055104A1Crystal form of heteroaryl derivative parp inhibitor and use thereofHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2023·Application pending·0 cites
- 0535US11974985B2Composition of aminopyran derivativeHAISCO PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted May 7, 2024·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when HAISCO PHARMACEUTICAL GROUP CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →